TripleTree Capital Partners
Overview
TripleTree Capital Partners is an independent merchant bank specializing in healthcare-focused mergers and acquisitions, financial restructuring, and principal investing services. The firm has been advising and investing in innovative, high-growth healthcare businesses since 1997. The firm's investment strategy centers on providing growth capital to technology, healthcare, and business services companies. They focus on early to late-stage investments, including pre-IPO and buyouts, with investment sizes ranging from $1 million to $50 million. Their geographical focus is primarily on the United States, with a particular emphasis on the healthcare sector. TripleTree Capital Partners has a track record of successful investments in companies such as BioIntellisense, Propio Language Services, and NextHealth Technologies. Their approach combines deep industry knowledge with a commitment to driving value creation for their portfolio companies.
Investment Focus
- Healthcare focus
- Technology orientation
- Growth potential
- Established market presence
Portfolio Companies
Reach TripleTree Capital Partners directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about TripleTree Capital Partners
What sectors does TripleTree Capital Partners invest in?
TripleTree Capital Partners invests in Technology, Healthcare and Business Services, and is based in Minnesota, United States. TripleTree Capital Partners is listed as a private investment firm in the ConnectSafely investor database.
What stage does TripleTree Capital Partners invest at?
TripleTree Capital Partners backs companies at Early Stage, Growth, Late Stage, Pre-IPO and Buyout, writing cheques of 1M - 50M.
Which regions does TripleTree Capital Partners invest in?
TripleTree Capital Partners invests across United States.
What companies has TripleTree Capital Partners invested in?
TripleTree Capital Partners's portfolio includes BioIntelliSense, Propio Language Services and NextHealth Technologies.
Last updated · Source: ConnectSafely investor database
